Meilian Dong
1 Jianshe Road
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Dosimetric comparison of three different radiotherapy regimens for bilateral breast cancer.
Journal: Biomedical engineering online
Published: July 03, 2025
One-week regimen for postoperative regional irradiation in breast cancer: the ARROW trial protocol.
Journal: BMJ open
Published: May 16, 2025
Integrated WGCNA retrieval of T-cell exhaustion genes related to radiosensitivity in locally advanced cervical cancer and prediction of immunotherapy efficacy.
Journal: Discover oncology
Published: February 14, 2025
Genome-wide identification and analysis of epithelial-mesenchymal transition-related RNA-binding proteins and alternative splicing in a human breast cancer cell line.
Journal: Scientific reports
Published: February 12, 2024
Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial.
Journal: International journal of cancer
Published: July 25, 2022
Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma.
Journal: Bioscience reports
Published: June 02, 2022
The role of radiotherapy in neuroendocrine cervical cancer: SEER-based study.
Journal: Science progress
Published: April 13, 2021
Targeted Intraoperative Radiotherapy Is Non-inferior to Conventional External Beam Radiotherapy in Chinese Patients With Breast Cancer: A Propensity Score Matching Study.
Journal: Frontiers in oncology
Published: April 09, 2020
Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis.
Journal: Therapeutic advances in medical oncology
Published: February 19, 2020
A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients.
Journal: Cancer cell international
Published: December 31, 2019
MiR-499a-5p Inhibits Proliferation, Invasion, Migration, and Epithelial-Mesenchymal Transition, and Enhances Radiosensitivity of Cervical Cancer Cells via Targeting eIF4E.
Journal: OncoTargets and therapy
Published: December 09, 2019
Last Updated: 09/26/2026